{"id":49903,"date":"2022-11-23T10:44:35","date_gmt":"2022-11-23T09:44:35","guid":{"rendered":"https:\/\/www.aiom.it\/?p=49903"},"modified":"2022-11-23T10:44:35","modified_gmt":"2022-11-23T09:44:35","slug":"first-line-avelumab-for-patients-with-pd-l1-positive-metastatic-or-locally-advanced-urothelial-cancer-who-are-unfit-for-cisplatin","status":"publish","type":"post","link":"https:\/\/www.aiom.it\/en\/first-line-avelumab-for-patients-with-pd-l1-positive-metastatic-or-locally-advanced-urothelial-cancer-who-are-unfit-for-cisplatin\/","title":{"rendered":"First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin"},"content":{"rendered":"<p>&nbsp;<\/p>\n<p><em>R Iacovelli, C Ciccarese, M Brunelli, N Battelli, C Buttigliero, C Caserta, S Buti, D Santini, C Carella, L Galli, E Verri, P Ermacora, S Merler, C Masini, R De Vivo, L Milesi, F Spina, M Rizzo, I Sperduti, G Fornarini, G Tortora <img loading=\"lazy\" decoding=\"async\" class=\"alignright size-medium wp-image-36444\" src=\"https:\/\/www.aiom.it\/wp-content\/uploads\/2020\/04\/AnnalsOfOncology-225x300.jpg\" alt=\"\" width=\"225\" height=\"300\" srcset=\"https:\/\/www.aiom.it\/wp-content\/uploads\/2020\/04\/AnnalsOfOncology-225x300.jpg 225w, https:\/\/www.aiom.it\/wp-content\/uploads\/2020\/04\/AnnalsOfOncology.jpg 575w\" sizes=\"auto, (max-width: 225px) 100vw, 225px\" \/><\/em><\/p>\n<p><em>Annals of Oncology, Nov. 22<\/em><\/p>\n<p style=\"text-align: right;\"><a href=\"https:\/\/www.annalsofoncology.org\/article\/S0923-7534(22)01862-2\/fulltext#secsectitle0120\">Abstract link<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>\u00a9 2022 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; R Iacovelli, C Ciccarese, M Brunelli, N Battelli, C Buttigliero, C Caserta, S Buti, D Santini, C Carella, L Galli, E Verri, P Ermacora, S Merler, C Masini, R De Vivo, L Milesi, F Spina, M Rizzo, I Sperduti, G Fornarini, G Tortora Annals of Oncology, Nov. 22 Abstract link &nbsp; &nbsp; &nbsp; &nbsp; [&hellip;]<\/p>\n","protected":false},"author":11,"featured_media":36447,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[255],"tags":[],"class_list":["post-49903","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articoli-scientifici-en"],"_links":{"self":[{"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/posts\/49903","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/comments?post=49903"}],"version-history":[{"count":2,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/posts\/49903\/revisions"}],"predecessor-version":[{"id":49905,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/posts\/49903\/revisions\/49905"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/media\/36447"}],"wp:attachment":[{"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/media?parent=49903"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/categories?post=49903"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/tags?post=49903"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}